Conference Coverage

Does reduced degradation of insulin by the liver cause type 2 diabetes?


 

EXPERT ANALYSIS FROM WCIRDC 2018

In some individuals, reduced degradation of insulin by the liver is the cause of type 2 diabetes mellitus.

of Cedars-Sinai Medical Center, Los Angeles Doug Brunk/MDedge News

Dr. Richard N. Bergman

That’s a hypothesis that Richard N. Bergman, PhD, and his colleagues are testing in his lab at the Sports Spectacular Diabetes and Obesity Wellness and Research Center at Cedars-Sinai Medical Center, Los Angeles.

“More than 50% of insulin secreted into the portal vein is degraded by the liver and never enters the systemic circulation,” Dr. Bergman said at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease. “We have found that if you make an animal insulin resistant with a high fat diet, they degrade less of the insulin. Why is that? They deliver a higher fraction of the insulin into the systemic circulation. One of the answers is that the liver is a gateway for insulin delivery to the systemic circulation.” In fact, when he and his colleagues tested a population of normal dogs, they found wide variability in the ability of the liver to take up and degrade insulin (Diabetes. 2018 67[8]:1495-503).

“It ranged from 20% to 70%; I didn’t believe these data,” said Dr. Bergman, who is also chair in diabetes research at Cedars-Sinai. “We had to redo the study and the same thing was true. There’s a wide variation in what fraction of insulin that enters the liver is degraded. That led to the idea that this could be true in humans.”

Pages

Recommended Reading

EHRs and Burnout
MDedge Endocrinology
Expert calls for better ways to preserve beta cell function in youth
MDedge Endocrinology
Cerebral small vessel and cognitive impairment
MDedge Endocrinology
Quincy the (diabetic) koala leaves behind more than memories
MDedge Endocrinology
New diabetes drugs solidify their cardiovascular and renal benefits
MDedge Endocrinology
Prenatal valproate and ADHD
MDedge Endocrinology
Osteomyelitis amputation risk linked to comorbidity burden
MDedge Endocrinology
Researchers exploring ways to mitigate aging’s impact on diabetes
MDedge Endocrinology
Postprandial glucose responses to identical meals vary from person to person
MDedge Endocrinology
Torrent Pharmaceuticals expands losartan recall
MDedge Endocrinology